Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.110
+0.020 (1.83%)
At close: Mar 6, 2026, 4:00 PM EST
1.120
+0.010 (0.90%)
After-hours: Mar 6, 2026, 6:38 PM EST
Humacyte Market Cap
Humacyte has a market cap or net worth of $214.23 million as of March 6, 2026. Its market cap has decreased by -56.98% in one year.
Market Cap
214.23M
Enterprise Value
245.71M
1-Year Change
-56.98%
Ranking
Category
Stock Price
$1.11
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $214.23M, an increase of 72.34%. That is a compound annual growth rate of 10.90%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Keros Therapeutics | 219.65M |
| Alector | 219.62M |
| Sol-Gel Technologies | 219.07M |
| Eledon Pharmaceuticals | 217.82M |
| MediWound | 216.96M |
| Cibus | 216.18M |
| Protalix BioTherapeutics | 214.32M |
| Voyager Therapeutics | 214.06M |